Combinatorial Chemistry & High Throughput Screening
Title:Doctoral Degree Surplus and Dwindling Quality: A Perilous Blend for Young Scientists in Tackling COVID-19 Like Pandemics
Volume: 23 Issue: 7
Author(s): Deepak Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Sharma Deepak , Doctoral Degree Surplus and Dwindling Quality: A Perilous Blend for Young Scientists in Tackling COVID-19 Like Pandemics, Combinatorial Chemistry & High Throughput Screening 2020; 23 (7) . https://dx.doi.org/10.2174/138620732307200713115636
DOI https://dx.doi.org/10.2174/138620732307200713115636 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiviral Activity and Molecular Targets of Plant Natural Products Against Avian Influenza Virus
Current Organic Chemistry Death Due to COVID-19 in an Infant with Combined Immunodeficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
Coronaviruses Emergence of a New Zoonotic COVID-19 that Creates a Pandemic: Update on Current Pharmacotherapeutics and Future Prospective of Plasma Therapy
Coronaviruses COVID-19 Pandemic: Age and Temperature Related Effects
Coronaviruses COVID-19 Related Publications Focusing on Cancer: Systematic Review of a Delicate Balance
Clinical Cancer Drugs Postpartum Posterior Reversible Encephalopathy Syndrome in a Patient Suspected to COVID-19
Anti-Infective Agents Withdrawal Notice: Identification of the Interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2
Current Pharmaceutical Design Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19
Current Medicinal Chemistry Intracellular Delivery: Exploiting Viral Membranotropic Peptides
Current Drug Metabolism Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy
Current Medicinal Chemistry ACE and ACE2 in Inflammation: A Tale of Two Enzymes
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Recognition of Human Angiotensin-Coverting Enzyme I (hACE I) and Different Inhibitors
Current Topics in Medicinal Chemistry Effectiveness of a Lockdown Policy During a Global Pandemic
Current Chinese Science Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates
Recent Patents on Biotechnology Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A Hypothetical View
Endocrine, Metabolic & Immune Disorders - Drug Targets The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews SARS-CoV-2: The Path of Prevention and Control
Infectious Disorders - Drug Targets